43 research outputs found
Cross-language Ontology Learning: Incorporating and Exploiting Cross-language Data in the Ontology Learning Process
Hans Hjelm. Cross-language Ontology Learning:
Incorporating and Exploiting Cross-language Data in the Ontology Learning Process.
NEALT Monograph Series, Vol. 1 (2009), 159 pages.
© 2009 Hans Hjelm.
Published by
Northern European Association for Language
Technology (NEALT)
http://omilia.uio.no/nealt .
Electronically published at
Tartu University Library (Estonia)
http://hdl.handle.net/10062/10126
Identifying Cross Language Term Equivalents Using Statistical Machine Translation and Distributional Association Measures
Proceedings of the 16th Nordic Conference
of Computational Linguistics NODALIDA-2007.
Editors: Joakim Nivre, Heiki-Jaan Kaalep, Kadri Muischnek and Mare Koit.
University of Tartu, Tartu, 2007.
ISBN 978-9985-4-0513-0 (online)
ISBN 978-9985-4-0514-7 (CD-ROM)
pp. 97-104
Using Semantic Features Derived from Word-Space Models for Swedish Coreference Resolution
Proceedings of the 17th Nordic Conference of Computational Linguistics
NODALIDA 2009.
Editors: Kristiina Jokinen and Eckhard Bick.
NEALT Proceedings Series, Vol. 4 (2009), 134-141.
© 2009 The editors and contributors.
Published by
Northern European Association for Language
Technology (NEALT)
http://omilia.uio.no/nealt .
Electronically published at
Tartu University Library (Estonia)
http://hdl.handle.net/10062/9206
Genetic ablation of soluble TNF does not affect lesion size and functional recovery after moderate spinal cord injury in mice
Traumatic spinal cord injury (SCI) is followed by an instant increase in expression of the microglial-derived proinflammatory cytokine tumor necrosis factor (TNF) within the lesioned cord. TNF exists both as membrane-anchored TNF (mTNF) and as cleaved soluble TNF (solTNF). We previously demonstrated that epidural administration of a dominant-negative inhibitor of solTNF, XPro1595, to the contused spinal cord resulted in changes in Iba1 protein expression in microglia/macrophages, decreased lesion volume, and improved locomotor function. Here, we extend our studies using mice expressing mTNF, but no solTNF (mTNFΔ/Δ), to study the effect of genetic ablation of solTNF on SCI. We demonstrate that TNF levels were significantly decreased within the lesioned spinal cord 3 days after SCI in mTNFΔ/Δ mice compared to littermates. This decrease did, however, not translate into significant changes in other pro- and anti-inflammatory cytokines (IL-10, IL-1β, IL-6, IL-5, IL-2, CXCL1, CCL2, or CCL5), despite a tendency towards increased IL-10 and decreased IL-1β, TNFR1, and TNFR2 levels in mTNFΔ/Δ mice. In addition, microglial and leukocyte infiltration, activation state (Iba1, CD11b, CD11c, CD45, and MHCII), lesion size, and functional outcome after moderate SCI were comparable between genotypes. Collectively, our data demonstrate that genetic ablation of solTNF does not significantly modulate postlesion outcome after SCI
Genetic Ablation of Soluble TNF Does Not Affect Lesion Size and Functional Recovery after Moderate Spinal Cord Injury in Mice
Traumatic spinal cord injury (SCI) is followed by an instant increase in expression of the microglial-derived proinflammatory cytokine tumor necrosis factor (TNF) within the lesioned cord. TNF exists both as membrane-anchored TNF (mTNF) and as cleaved soluble TNF (solTNF). We previously demonstrated that epidural administration of a dominant-negative inhibitor of solTNF, XPro1595, to the contused spinal cord resulted in changes in Iba1 protein expression in microglia/macrophages, decreased lesion volume, and improved locomotor function. Here, we extend our studies using mice expressing mTNF, but no solTNF (mTNF Δ/Δ ), to study the effect of genetic ablation of solTNF on SCI. We demonstrate that TNF levels were significantly decreased within the lesioned spinal cord 3 days after SCI in mTNF Δ/Δ mice compared to littermates. This decrease did, however, not translate into significant changes in other pro-and anti-inflammatory cytokines (IL-10, IL-1 , IL-6, IL-5, IL-2, CXCL1, CCL2, or CCL5), despite a tendency towards increased IL-10 and decreased IL-1 , TNFR1, and TNFR2 levels in mTNF Δ/Δ mice. In addition, microglial and leukocyte infiltration, activation state (Iba1, CD11b, CD11c, CD45, and MHCII), lesion size, and functional outcome after moderate SCI were comparable between genotypes. Collectively, our data demonstrate that genetic ablation of solTNF does not significantly modulate postlesion outcome after SCI